CIK 0000718937
- Large accelerated filer
STAAR SURGICAL CO
Sign in to watch- Ticker
- STAA
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Jan 2
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953797439
- Phone
- +1 626-303-7902
- Business address
- 1911 WALKER AVE, MONROVIA, CA, 91016
- Former names
- STAAR SURGICAL COMPANY
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-19 | Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China | Exercise or conversion | −12,156 | $82.02 | $997K | 127,950 |
| 2020-11-19 | Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China | Sale | −14,007 | $82.03 | $1.1M | 113,943 |
| 2020-11-19 | Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China | Exercise or conversion · Common Stock Options | −12,156 | 2,844 | ||
| 2020-11-16 | Barnes Scott D Chief Medical Officer | Exercise or conversion | +5,430 | $29.80 | $162K | 25,820 |
| 2020-11-16 | Barnes Scott D Chief Medical Officer | Exercise or conversion | +17,163 | $35.98 | $618K | 42,983 |
| 2020-11-16 | Barnes Scott D Chief Medical Officer | Exercise or conversion | −22,593 | $80.25 | $1.8M | 20,390 |
| 2020-11-16 | Barnes Scott D Chief Medical Officer | Exercise or conversion · Common Stock Options | −5,430 | 1,312 | ||
| 2020-11-16 | Barnes Scott D Chief Medical Officer | Exercise or conversion · Common Stock Options | −17,163 | 13,731 | ||
| 2020-11-09 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +10,200 | $29.80 | $304K | 20,994 |
| 2020-11-09 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +9,800 | $16.15 | $158K | 30,794 |
| 2020-11-09 | Hayashida Jon K. VP, Global Clinical, Medical | Sale | −20,000 | $81.34 | $1.6M | 10,794 |
| 2020-11-09 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion · Common Stock Options | −10,200 | 1,058 | ||
| 2020-11-09 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion · Common Stock Options | −9,800 | 724 | ||
| 2020-11-09 | Holliday Keith Chief Technology Officer | Exercise or conversion | +23,714 | $7.52 | $178K | 43,046 |
| 2020-11-09 | Holliday Keith Chief Technology Officer | Exercise or conversion | +15,000 | $9.30 | $140K | 58,046 |
| 2020-11-09 | Holliday Keith Chief Technology Officer | Sale | −23,714 | $81.56 | $1.9M | 34,332 |
| 2020-11-09 | Holliday Keith Chief Technology Officer | Exercise or conversion · Common Stock Options | −23,714 | 0 | ||
| 2020-11-09 | Holliday Keith Chief Technology Officer | Exercise or conversion · Common Stock Options | −15,000 | 0 | ||
| 2020-11-09 | Moore John C Director | Exercise or conversion | +5,000 | $10.31 | $52K | 7,117 |
| 2020-11-09 | Moore John C Director | Exercise or conversion | +10,000 | $15.73 | $157K | 17,117 |
Page 39 of 50 · 987 trades